314 related articles for article (PubMed ID: 12063524)
1. Effect of desloratadine versus placebo on nasal airflow and subjective measures of nasal obstruction in subjects with grass pollen-induced allergic rhinitis in an allergen-exposure unit.
Horak F; Stübner UP; Zieglmayer R; Harris AG
J Allergy Clin Immunol; 2002 Jun; 109(6):956-61. PubMed ID: 12063524
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the effects of desloratadine 5-mg daily and placebo on nasal airflow and seasonal allergic rhinitis symptoms induced by grass pollen exposure.
Horak F; Stübner P; Zieglmeyer R; Harris AG
Allergy; 2003 Jun; 58(6):481-5. PubMed ID: 12757447
[TBL] [Abstract][Full Text] [Related]
3. A review of the efficacy of desloratadine, fexofenadine, and levocetirizine in the treatment of nasal congestion in patients with allergic rhinitis.
Bachert C
Clin Ther; 2009 May; 31(5):921-44. PubMed ID: 19539095
[TBL] [Abstract][Full Text] [Related]
4. Petasol butenoate complex (Ze 339) relieves allergic rhinitis-induced nasal obstruction more effectively than desloratadine.
Dumitru AF; Shamji M; Wagenmann M; Hindersin S; Scheckenbach K; Greve J; Klenzner T; Hess L; Nebel S; Zimmermann C; Zahner C; Schmidt-Weber CB; Chaker AM
J Allergy Clin Immunol; 2011 Jun; 127(6):1515-21.e6. PubMed ID: 21489609
[TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of desloratadine 5 mg in asthma patients with seasonal allergic rhinitis and nasal congestion.
Berger WE; Schenkel EJ; Mansfield LE;
Ann Allergy Asthma Immunol; 2002 Nov; 89(5):485-91. PubMed ID: 12452207
[TBL] [Abstract][Full Text] [Related]
6. Effect of desloratadine therapy on symptom scores and measures of nasal patency in seasonal allergic rhinitis: results of a single-center, placebo-controlled trial.
Meltzer EO; Jalowayski AA; Vogt K; Iezzoni D; Harris AG
Ann Allergy Asthma Immunol; 2006 Feb; 96(2):363-8. PubMed ID: 16498861
[TBL] [Abstract][Full Text] [Related]
7. Comparison of ketotifen fumarate ophthalmic solution alone, desloratadine alone, and their combination for inhibition of the signs and symptoms of seasonal allergic rhinoconjunctivitis in the conjunctival allergen challenge model: a double-masked, placebo- and active-controlled trial.
Crampton HJ
Clin Ther; 2003 Jul; 25(7):1975-87. PubMed ID: 12946545
[TBL] [Abstract][Full Text] [Related]
8. Impact and modulation of nasal obstruction.
Horak F
Allergy; 2002; 57 Suppl 75():25-8. PubMed ID: 12492726
[TBL] [Abstract][Full Text] [Related]
9. Levocetirizine improves nasal obstruction and modulates cytokine pattern in patients with seasonal allergic rhinitis: a pilot study.
Ciprandi G; Cirillo I; Vizzaccaro A; Tosca MA
Clin Exp Allergy; 2004 Jun; 34(6):958-64. PubMed ID: 15196286
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of once-daily desloratadine/pseudoephedrine for relief of nasal congestion.
Schenkel E; Corren J; Murray JJ
Allergy Asthma Proc; 2002; 23(5):325-30. PubMed ID: 12476542
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of diphenhydramine vs desloratadine and placebo in patients with moderate-to-severe seasonal allergic rhinitis.
Raphael GD; Angello JT; Wu MM; Druce HM
Ann Allergy Asthma Immunol; 2006 Apr; 96(4):606-14. PubMed ID: 16680933
[TBL] [Abstract][Full Text] [Related]
12. Desloratadine reduces allergen challenge-induced mucinous secretion and plasma exudation in allergic rhinitis.
Greiff L; Persson CG; Andersson M
Ann Allergy Asthma Immunol; 2002 Oct; 89(4):413-8. PubMed ID: 12392387
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of an extended-release formulation of desloratadine and pseudoephedrine vs the individual components in the treatment of seasonal allergic rhinitis.
Pleskow W; Grubbe R; Weiss S; Lutsky B
Ann Allergy Asthma Immunol; 2005 Mar; 94(3):348-54. PubMed ID: 15801245
[TBL] [Abstract][Full Text] [Related]
14. Effects of fexofenadine and desloratadine on subjective and objective measures of nasal congestion in seasonal allergic rhinitis.
Wilson AM; Haggart K; Sims EJ; Lipworth BJ
Clin Exp Allergy; 2002 Oct; 32(10):1504-9. PubMed ID: 12372132
[TBL] [Abstract][Full Text] [Related]
15. Azelastine nasal spray and desloratadine tablets in pollen-induced seasonal allergic rhinitis: a pharmacodynamic study of onset of action and efficacy.
Horak F; Zieglmayer UP; Zieglmayer R; Kavina A; Marschall K; Munzel U; Petzold U
Curr Med Res Opin; 2006 Jan; 22(1):151-7. PubMed ID: 16393441
[TBL] [Abstract][Full Text] [Related]
16. Desloratadine reduces nasal congestion in patients with intermittent allergic rhinitis.
Nayak AS; Schenkel E
Allergy; 2001 Nov; 56(11):1077-80. PubMed ID: 11703222
[TBL] [Abstract][Full Text] [Related]
17. Effects of rupatadine vs placebo on allergen-induced symptoms in patients exposed to aeroallergens in the Vienna Challenge Chamber.
Stuebner P; Horak F; Zieglmayer R; Arnáiz E; Leuratti C; Pérez I; Izquierdo I
Ann Allergy Asthma Immunol; 2006 Jan; 96(1):37-44. PubMed ID: 16440531
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of desloratadine/pseudoephedrine combination vs its components in seasonal allergic rhinitis.
Grubbe RE; Lumry WR; Anolik R
J Investig Allergol Clin Immunol; 2009; 19(2):117-24. PubMed ID: 19476015
[TBL] [Abstract][Full Text] [Related]
19. Desloratadine for the treatment of cypress pollen-induced allergic rhinitis.
Demoly P; Dreyfus I; Dhivert-Donnadieu H; Mesbah K
Ann Allergy Asthma Immunol; 2009 Sep; 103(3):260-6. PubMed ID: 19788025
[TBL] [Abstract][Full Text] [Related]
20. Desloratadine relieves nasal congestion and improves quality-of-life in persistent allergic rhinitis.
Holmberg K; Tonnel AB; Dreyfus I; Olsson P; Cougnard J; Mesbah K; Devillier P
Allergy; 2009 Nov; 64(11):1663-70. PubMed ID: 19740126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]